Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,278 | -16,266 | -14,009 | -31,554 | -25,812 |
| Depreciation Amortization | 673 | 452 | 222 | 863 | 693 |
| Accounts receivable | 11 | -2 | -35 | 54 | 23 |
| Accounts payable and accrued liabilities | -1,904 | -1,590 | -2,055 | 2,037 | 248 |
| Other Working Capital | 1,054 | 577 | -678 | 2,022 | 793 |
| Other Operating Activity | 6,932 | 6,543 | 10,602 | 6,503 | 8,016 |
| Operating Cash Flow | $-15,512 | $-10,286 | $-5,953 | $-20,075 | $-16,039 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -307 | -211 | -79 | -360 | -162 |
| Investing Cash Flow | $-307 | $-211 | $-79 | $-360 | $-162 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 47,118 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 2,004 | 1,730 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $49,122 | $1,730 |
| Exchange Rate Effect | 1 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 60,033 | 60,033 | 60,033 | 31,346 | 31,346 |
| End Cash Position | 44,215 | 49,536 | 54,001 | 60,033 | 16,875 |
| Net Cash Flow | $-15,818 | $-10,497 | $-6,032 | $28,687 | $-14,471 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,512 | -10,286 | -5,953 | -20,075 | -16,039 |
| Capital Expenditure | -307 | -211 | -79 | -360 | -162 |
| Free Cash Flow | -15,819 | -10,497 | -6,032 | -20,435 | -16,201 |